Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy

Autologous skeletal myoblast transplantation might improve postinfarction ventricular function, but graft viability and differentiation (ie, proof of concept) has not been shown. A 72-year-old man had autologous cultured myoblasts from his vastus lateralis injected to an area of transmural inferior...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) Vol. 361; no. 9356; pp. 491 - 492
Main Authors: Hagège, Albert A, Carrion, Claire, Menasché, Philippe, Vilquin, Jean-Thomas, Duboc, Denis, Marolleau, Jean-Pierre, Desnos, Michel, Bruneval, Patrick
Format: Journal Article
Language:English
Published: London Elsevier Ltd 08-02-2003
Lancet
Elsevier Limited
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Autologous skeletal myoblast transplantation might improve postinfarction ventricular function, but graft viability and differentiation (ie, proof of concept) has not been shown. A 72-year-old man had autologous cultured myoblasts from his vastus lateralis injected to an area of transmural inferior myocardial infarction in non-reperfused scar tissue. He showed improvement in symptoms and left-ventricular ejection fraction. When he died 17·5 months after the procedure, the grafted post-infarction scar showed well developed skeletal myotubes with a preserved contractile apparatus. 65% of myotubes expressed the slow myosin isoform and 33% coexpressed the slow and fast isoforms ( vs 44% and 0·6%, respectively, in skeletal muscle). Myoblast grafts can survive and show a switch to slow-twitch fibres, which might allow sustained improvement in cardiac function.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(03)12458-0